Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 1/2018

01-02-2018 | Case Report

Unclassified hepatocellular adenoma in a middle-aged woman with glucose intolerance

Authors: Kumi Ozaki, Kenichi Harada, Toru Yamamoto, Hiroyuki Aoyagi, Yasuharu Kaizaki, Jun Yoshikawa

Published in: Clinical Journal of Gastroenterology | Issue 1/2018

Login to get access

Abstract

The patient was a 43-year-old woman with obesity (body mass index: 29.1) and glucose intolerance who was not taking oral contraceptives. An ultrasound showed a hypoechoic hepatic mass. Dynamic contrast-enhanced computed tomography revealed a lesion in segment 6 that showed homogeneous and slight-to-moderate enhancement in the arterial phase with persistent enhancement during the portal and equilibrium phases. On magnetic resonance (MR) imaging, the lesion demonstrated hyperintensity on T2- and diffusion-weighted images and hypointensity in the hepatobiliary phase of gadoxetic-acid-enhanced MR imaging. In addition to the main lesion, approximately ten small hypointense lesions were seen in the hepatobiliary phase. The background liver was fatty without the deformity of chronic liver disease. Based on the pathological findings of the main lesion biopsy, it was initially suspected to be a non-neoplastic lesion with hematoxylin and eosin staining and initial immunohistochemical staining. However, the radiological findings indicated a neoplastic lesion. Additional immunohistochemical staining, including that for α-smooth muscle actin and organic anion transporter polypeptide 1B3, in combination with the radiological findings resulted in a diagnosis of unclassified hepatocellular adenoma. The other small lesions were presumed to be related to the main lesion.
Literature
1.
go back to reference Zucman-Rossi J, Jeannot E, Nhieu JT, et al. Genotype–phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology. 2006;43:515–24.CrossRefPubMed Zucman-Rossi J, Jeannot E, Nhieu JT, et al. Genotype–phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology. 2006;43:515–24.CrossRefPubMed
2.
go back to reference Bioulac-Sage P, Laumonier H, Couchy G, et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology. 2009;50:481–9.CrossRefPubMed Bioulac-Sage P, Laumonier H, Couchy G, et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology. 2009;50:481–9.CrossRefPubMed
3.
go back to reference Bioulac-Sage P, Rebouissou S, Thomas C, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology. 2007;46:740–8.CrossRefPubMed Bioulac-Sage P, Rebouissou S, Thomas C, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology. 2007;46:740–8.CrossRefPubMed
4.
go back to reference Katabathina VS, Menias CO, Shanbhogue AKP, et al. Genetics and imaging of hepatocellular adenomas: 2011 update. RadioGraphics. 2011;31:1529–43.CrossRefPubMed Katabathina VS, Menias CO, Shanbhogue AKP, et al. Genetics and imaging of hepatocellular adenomas: 2011 update. RadioGraphics. 2011;31:1529–43.CrossRefPubMed
5.
go back to reference Tse JR, Naini BV, Lu DS, et al. Qualitative and quantitative gadoxetic acid-enhanced MR imaging helps subtype hepatocellular adenomas. Radiology. 2016;279:118–27.CrossRefPubMed Tse JR, Naini BV, Lu DS, et al. Qualitative and quantitative gadoxetic acid-enhanced MR imaging helps subtype hepatocellular adenomas. Radiology. 2016;279:118–27.CrossRefPubMed
6.
go back to reference Ba-Ssalamah A, Antunes C, Feier D, et al. Morphologic and molecular features of hepatocellular adenoma with gadoxetic acid-enhanced MR imaging. Rdiology. 2015;277:104–13. Ba-Ssalamah A, Antunes C, Feier D, et al. Morphologic and molecular features of hepatocellular adenoma with gadoxetic acid-enhanced MR imaging. Rdiology. 2015;277:104–13.
7.
go back to reference Grazioli L, Bondioni MP, Haradome H, et al. Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology. 2012;262:520–9.CrossRefPubMed Grazioli L, Bondioni MP, Haradome H, et al. Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology. 2012;262:520–9.CrossRefPubMed
8.
go back to reference van Aalten SM, Thomeer MG, Terkivatan T, et al. Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology. 2011;261:172–81.CrossRefPubMed van Aalten SM, Thomeer MG, Terkivatan T, et al. Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology. 2011;261:172–81.CrossRefPubMed
9.
go back to reference Sasaki M, Yoneda N, Kitamura S, et al. Characterization of hepatocellular adenoma based on the phenotypic classification: the Kanazawa experience. Hepatol Res. 2011;41:982–8.CrossRefPubMed Sasaki M, Yoneda N, Kitamura S, et al. Characterization of hepatocellular adenoma based on the phenotypic classification: the Kanazawa experience. Hepatol Res. 2011;41:982–8.CrossRefPubMed
10.
go back to reference Fukusato T, Soejima Y, Kondo F, et al. Preserved or enhanced OATP1B3 expression in hepatocellular adenoma subtypes with nuclear accumulation of β-catenin. Hepatol Res. 2015;45:E32–42.CrossRefPubMed Fukusato T, Soejima Y, Kondo F, et al. Preserved or enhanced OATP1B3 expression in hepatocellular adenoma subtypes with nuclear accumulation of β-catenin. Hepatol Res. 2015;45:E32–42.CrossRefPubMed
11.
go back to reference Bambha K, Nagorney D, Sanderson S, et al. Hepatic adenomatosis in a young woman with glucose intolerance. Nat Clin Pract Gastroenterol Hepatol. 2006;3:526–31.CrossRefPubMed Bambha K, Nagorney D, Sanderson S, et al. Hepatic adenomatosis in a young woman with glucose intolerance. Nat Clin Pract Gastroenterol Hepatol. 2006;3:526–31.CrossRefPubMed
12.
go back to reference Yoneda N, Matsui O, Kitao A, et al. Beta-catenin-activated hepatocellular adenoma showing hyperintensity on hepatobiliary-phase gadoxetic-enhanced magnetic resonance imaging and overexpression of OATP8. Jpn J Radiol. 2012;30:777–82.CrossRefPubMed Yoneda N, Matsui O, Kitao A, et al. Beta-catenin-activated hepatocellular adenoma showing hyperintensity on hepatobiliary-phase gadoxetic-enhanced magnetic resonance imaging and overexpression of OATP8. Jpn J Radiol. 2012;30:777–82.CrossRefPubMed
13.
go back to reference Lagana SM, Salomao M, Bao F, et al. Utility of an immunohistochemical panel consisting of glypican-3, heat-shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma. Appl Immunohistochem Mol Morphol. 2013;21:170–6.PubMed Lagana SM, Salomao M, Bao F, et al. Utility of an immunohistochemical panel consisting of glypican-3, heat-shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma. Appl Immunohistochem Mol Morphol. 2013;21:170–6.PubMed
14.
go back to reference Kitao A, Matsui O, Yoneda N, et al. The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging. Eur Radiol. 2011;21:2056–66.CrossRefPubMed Kitao A, Matsui O, Yoneda N, et al. The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging. Eur Radiol. 2011;21:2056–66.CrossRefPubMed
15.
go back to reference Kitao A, Zen Y, Matsui O, et al. Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging–correlation with molecular transporters and histopathologic features. Radiology. 2010;256:817–26.CrossRefPubMed Kitao A, Zen Y, Matsui O, et al. Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging–correlation with molecular transporters and histopathologic features. Radiology. 2010;256:817–26.CrossRefPubMed
16.
go back to reference Yoneda N, Matsui O, Kitao A, et al. Hepatocyte transporter expression in FNH and FNH-like nodule: correlation with signal intensity on gadoxetic acid enhanced magnetic resonance images. Jpn J Radiol. 2012;30:499–508.CrossRefPubMed Yoneda N, Matsui O, Kitao A, et al. Hepatocyte transporter expression in FNH and FNH-like nodule: correlation with signal intensity on gadoxetic acid enhanced magnetic resonance images. Jpn J Radiol. 2012;30:499–508.CrossRefPubMed
Metadata
Title
Unclassified hepatocellular adenoma in a middle-aged woman with glucose intolerance
Authors
Kumi Ozaki
Kenichi Harada
Toru Yamamoto
Hiroyuki Aoyagi
Yasuharu Kaizaki
Jun Yoshikawa
Publication date
01-02-2018
Publisher
Springer Japan
Published in
Clinical Journal of Gastroenterology / Issue 1/2018
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-017-0788-2

Other articles of this Issue 1/2018

Clinical Journal of Gastroenterology 1/2018 Go to the issue